CAS 55481-88-4
:Mollugin
- 2H-naphtho[1,2-b]pyran-5-carboxylic acid, 6-hydroxy-2,2-dimethyl-, methyl ester
- Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate
- Rubimaillin
- Smb 00431
- Mollugin
- 2H-Naphtho[1,2-b]pyran-5-carboxylic acid
- Mollugin/rubiMaillin
- 6-Hydroxy-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester
- Mollugin, 98%, from Rubia cordifolia L.
- 6-hydroxy-2, 2-dimethyl-, methylester
- RUBIMAILLIN; MOLLUGIN
- 2-DiMethyl-6-hydroxy-2H-naphtho[1,2-b]pyran-5-carboxylic acid Methyl ester
- 6-Hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylic Acid Methyl Ester
- 2,2-Dimethyl-6-hydroxy-2H-naphtho[1,2-b]pyran-5-carboxylic acid methyl ester
- MOLLUGIN(SH)
- Weitere Synonyme anzeigen
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Mollugin
CAS:Formel:C17H16O4Reinheit:>98.0%(HPLC)Farbe und Form:White to Yellow to Orange powder to crystalMolekulargewicht:284.31Methyl 6-Hydroxy-2,2-Dimethyl-2H-Benzo[H]Chromene-5-Carboxylate
CAS:Methyl 6-Hydroxy-2,2-Dimethyl-2H-Benzo[H]Chromene-5-CarboxylateFormel:C17H16O4Reinheit:99%Molekulargewicht:284.31Mollugin
CAS:Mollugin is a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway. Mollugin may be a novel therapeutic candidate for bone loss-associated disorders including osteoporosis, rheumatoid arthritis, and periodontitis. Mollugin has anticancer efficacy, can modulate the HER2, HO-1, Nrf2 , and NF- κB pathways.Formel:C17H16O4Reinheit:95%~99%Molekulargewicht:284.311Mollugin (Standard)
CAS:Mollugin (Standard) is the standard for Mollugin. Mollugin selectively inhibits the NLRP3 inflammasome, coordinately regulates inflammation and oxidative stress to promote regeneration, and induces ferroptosis in NSCLC while inhibiting tumor growth in vivo.Formel:C17H16O4Molekulargewicht:284.31Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate
CAS:Formel:C17H16O4Reinheit:%Farbe und Form:SolidMolekulargewicht:284.3065Mollugin
CAS:Mollugin could be a JAK2 inhibitor, anti-inflammatory, chemotherapeutic agent in OSCCs, bone disorder therapy, and modulates HER2 in cancer.Formel:C17H16O4Reinheit:99.87% - ≥95%Farbe und Form:SolidMolekulargewicht:284.31Mollugin
CAS:Oxygen-heterocyclic compoundFormel:C17H16O4Reinheit:≥ 95.0 % (HPLC)Molekulargewicht:284.31Mollugin
CAS:Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylateFormel:C17H16O4Reinheit:98+%Molekulargewicht:284.31Methyl 6-hydroxy-2,2-dimethyl-2H-benzo[h]chromene-5-carboxylate
CAS:Reinheit:≥98%(HPLC)Molekulargewicht:284.3110046Mollugin
CAS:Kontrolliertes ProduktApplications Mollugin is an anti-tumor agent inducing apoptosis and autophagy in various cancer models.
References Zhang, L. et al.: Biochem. Biophys. Res. Comm., 450, 247 (2014); Idhayadhulla, A. et al.: Bioorg. Chem., 52, 77 (2014);Formel:C17H16O4Farbe und Form:NeatMolekulargewicht:284.31Mollugin
CAS:Mollugin is a bioactive compound, which is derived from the plant Rubia cordifolia. As a phytochemical, it is part of the anthraquinone family, isolated through extraction processes from the root of its source plant. Its mode of action involves modulating various biochemical pathways, notably exhibiting anti-inflammatory, anticancer, and antioxidant activities. These effects are primarily mediated through the inhibition of specific enzymes and signaling pathways, including the NF-κB and MAPK pathways, which are central to inflammatory and cancer processes.
Reinheit:Min. 95%











